These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22309085)

  • 1. Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in a rat model.
    Toblli JE; Cao G; Oliveri L; Angerosa M
    Inflamm Allergy Drug Targets; 2012 Feb; 11(1):66-78. PubMed ID: 22309085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrosative stress and apoptosis in non-anemic healthy rats induced by intravenous iron sucrose similars versus iron sucrose originator.
    Toblli JE; Cao G; Angerosa M
    Biometals; 2015 Apr; 28(2):279-92. PubMed ID: 25609135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous iron sucrose reverses anemia-induced cardiac remodeling, prevents myocardial fibrosis, and improves cardiac function by attenuating oxidative/nitrosative stress and inflammation.
    Toblli JE; Cao G; Rivas C; Giani JF; Dominici FP
    Int J Cardiol; 2016 Jun; 212():84-91. PubMed ID: 27038710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution and predictive hepatic gene expression of intravenous iron sucrose.
    Elford P; Bouchard J; Jaillet L; Pearson N; Rogue A; Sabadie C; Forster R
    J Pharmacol Toxicol Methods; 2013; 68(3):374-83. PubMed ID: 23624021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator.
    Stein J; Dignass A; Chow KU
    Curr Med Res Opin; 2012 Feb; 28(2):241-3. PubMed ID: 22181342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between original intravenous iron sucrose and iron sucrose similar preparations.
    Toblli JE; Cao G; Oliveri L; Angerosa M
    Arzneimittelforschung; 2009; 59(4):176-90. PubMed ID: 19517894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the extent of oxidative stress induced by intravenous ferumoxytol, ferric carboxymaltose, iron sucrose and iron dextran in a nonclinical model.
    Toblli JE; Cao G; Oliveri L; Angerosa M
    Arzneimittelforschung; 2011; 61(7):399-410. PubMed ID: 21899208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol and baseline data for a prospective open-label explorative randomized single-center comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD).
    Ziedan A; Bhandari S
    Trials; 2019 Apr; 20(1):194. PubMed ID: 30947751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of adverse event profile of intravenous iron sucrose and iron sucrose similar in postpartum and gynecologic operative patients.
    Lee ES; Park BR; Kim JS; Choi GY; Lee JJ; Lee IS
    Curr Med Res Opin; 2013 Feb; 29(2):141-7. PubMed ID: 23252876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do two intravenous iron sucrose preparations have the same efficacy?
    Rottembourg J; Kadri A; Leonard E; Dansaert A; Lafuma A
    Nephrol Dial Transplant; 2011 Oct; 26(10):3262-7. PubMed ID: 21355067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
    Pai AB; Boyd AV; McQuade CR; Harford A; Norenberg JP; Zager PG
    Pharmacotherapy; 2007 Mar; 27(3):343-50. PubMed ID: 17316146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the suitability of a Sprague Dawley rat model to assess intravenous iron preparations.
    Span K; Pieters EHE; Brinks V; Hennink WE; Schellekens H
    J Pharmacol Toxicol Methods; 2018; 91():7-17. PubMed ID: 29278742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of toxicity and oxidative stress induced by intravenous iron isomaltoside 1000 in a nonclinical model.
    Toblli JE; Cao G; Oliveri L; Angerosa M
    Arzneimittelforschung; 2011; 61(10):553-65. PubMed ID: 22164963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferrous sulfate, but not iron polymaltose complex, aggravates local and systemic inflammation and oxidative stress in dextran sodium sulfate-induced colitis in rats.
    Toblli JE; Cao G; Angerosa M
    Drug Des Devel Ther; 2015; 9():2585-97. PubMed ID: 26005335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Induction of Oxidative/Nitrosative Stress, Inflammation, and Apoptosis by a Ferric Carboxymaltose Copy Compared to Iron Sucrose in a Non-Clinical Model.
    Toblli JE; Cao G; Angerosa M
    J Clin Diagn Res; 2015 Dec; 9(12):FF08-12. PubMed ID: 26816915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness*.
    Pieracci FM; Stovall RT; Jaouen B; Rodil M; Cappa A; Burlew CC; Holena DN; Maier R; Berry S; Jurkovich J; Moore EE
    Crit Care Med; 2014 Sep; 42(9):2048-57. PubMed ID: 24797376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute injury with intravenous iron and concerns regarding long-term safety.
    Bishu K; Agarwal R
    Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S19-23. PubMed ID: 17699372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.
    Zheng H; Huang X; Zhang Q; Katz SD
    Kidney Int; 2006 Feb; 69(4):679-84. PubMed ID: 16395269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of oxidative/nitrosative stress and inflammation in lung tissue of rats exposed to different intravenous iron compounds.
    Toblli JE; Cao G; Giani JF; Dominici FP; Angerosa M
    Drug Des Devel Ther; 2017; 11():2251-2263. PubMed ID: 28814833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New rat models of iron sucrose-induced iron overload.
    Vu'o'ng Lê B; Khorsi-Cauet H; Villegier AS; Bach V; Gay-Quéheillard J
    Exp Biol Med (Maywood); 2011 Jul; 236(7):790-9. PubMed ID: 21685238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.